ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action
R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Melinta goes bankrupt / Never let a good crisis go to waste
Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin
Plazomicin EU marketing application is withdrawn: Near zero market value of newly approved antibacterials
Draft EMA antibacterial guidance: Analysis
Impact of PASTEUR: 9.9m lives saved, ROI of 125:1
Draft FDA guidance on anti-infectives for children: It’s (mostly) all about PK and safety
Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?
FDA workshop: Insights on inhaled antifungals and antibacterials
New mechanisms for antibiotic reimbursement in the United States: CMS’s IPPS FY2020 Final Rule
Assessing antibiotic value: DTR, fire extinguishers, and a view from Australia
Lessons in Discovery from Lynn Silver + Pro-con on alternatives to antibiotics
What does an antibiotic cost to develop? What is it worth? How to afford it?
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet